PET of HER2 Expression with a Novel (18)FAl Labeled Affibody

Background: Human epidermal growth factor receptor type 2 (HER2) is abundant in a wide variety of tumors and associated with the poor prognosis. Radiolabeled affibodies are potential candidates for detecting HER2-positive lesions. However, laborious multiple-step synthetic procedure and high abdomen...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yuping, Bai, Zhicheng, Huang, Qianhuan, Pan, Yunyun, Pan, Donghui, Wang, Lizhen, Yan, Junjie, Wang, Xinyu, Yang, Runlin, Yang, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463431/
https://www.ncbi.nlm.nih.gov/pubmed/28607591
http://dx.doi.org/10.7150/jca.18070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463431/
https://www.ncbi.nlm.nih.gov/pubmed/28607591
http://dx.doi.org/10.7150/jca.18070

Ejemplares similares